Pharmacy & 340B
Hall Render’s Pharmacy and 340B practice is one of the largest and most experienced in the country, helping health systems, hospitals, federally qualified health centers (“FQHCs”), pharmacies and suppliers navigate the complex regulatory and reimbursement landscape that governs prescription drug sourcing, delivery and payment. We provide practical, experience-based counsel that supports compliant, efficient pharmacy operations...Read More
The Hall Render Advantage
Our multidisciplinary team understands how pharmacy operations intersect with reimbursement, compliance, technology and patient care. By combining deep regulatory knowledge with real-world operational insight, we deliver practical solutions that help organizations protect resources, sustain compliance and advance safe, efficient care delivery.
Areas of Focus
- 340B
- 403(b) Tax-Sheltered Annuity Plans
- 503A Compounding Pharmacies
- 503B Compounding Pharmacies
- Automated Dispensing
- Boards of Pharmacy Enrollment/Certification
- Central Fill Pharmacy
- Compliance Programs
- Assessment
- Audit Advice
- Education and Communication
- Structure and Reporting
- Controlled Substances Act (individual and institutional registrations, ordering, dispensing)
- Current Good Manufacturing Practice Compliance
- Drug-Seeking Patients
- HIPAA/HITECH
- Immunization Matters
- Importation
- Infusion Pharmacies and Services
- Labor and Employment
- Mail Order Pharmacies
- Patient Safety/Quality Improvement
- Pharmaceutical Environmental Issues
- Pharmaceutical Manufacturing
- Pharmaceutical Pricing and Rebates
- Pharmacy Benefit Management Contracting and Regulatory Compliance
- Private Label Manufacturing
- Regulatory Compliance
- Civil Monetary Penalties Law - Relationships with Beneficiaries
- Controlled Substances Act
- Counterfeit Drugs
- Drug Quality and Security Act
- Food, Drug and Cosmetic Act
- Fraud and Abuse - Federal and State Anti-Kickback Statutes
- Medicare Part D
- Prescription Drug Marketing Act
- Stark Law - Relationships with Physicians
- Traditional Medicare and Medicaid
- Regulatory Enforcement Support and Litigation
- Centers for Medicare & Medicaid Services
- Drug Enforcement Administration
- False Claims Act Defense
- Office of Inspector General
- State Enforcement Agencies
- State Licensing and Practice Hearings/Litigation
- State Pharmacy and Pharmacist Enrollment/Certifications
- Supply Chain (product and related services agreements)
- Technology
- E-Prescribing and Telemedicine
- Electronic Medical Records
- Security
- Wholesale Distribution
Resources
-
DOL Finalizes PBM Fee Disclosure Rule for Self-Insured Health Plans
[11/13/26 ]
-
HRSA’s New FQHC Scope of Project Manual Affects Provider-Patient Relationships, Arrangements with Other Providers and 340B Operations
[09/04/26 ]
-
FDA Proposes Distributed Manufacturing Registration Pathway and Aligns Foreign Establishment Registration and Listing Requirements With Current Law
[07/29/26 ]